retatrutide structure RCSB PDB Retatrutide trifluoroacetate | 2381089-83-2 |

Roughly 24 percent of people taking the GLP-1 drug semaglutide (and 11 percent of placebo takers) report constipation, according to the package insert

It can also be prescribed for those who are overweight, with a BMI of 27 or higher, if they also have at least one weight-related health condition

Retail & Apparel: The Inventory Reckoning No One Planned For One of the clearest business impacts of GLP-1 adoption is showing up in fashion and apparel

If fatigue persists beyond four to six weeks, discuss with your provider

Some states require a prescription for purchase at pharmacies, though many retail pharmacies and online suppliers sell them without requiring one

Individuals under 18 may be eligible for certain treatment options but need to talk with their health care provider